A Prophylactic Contraceptive for HIV/AIDs
The present technology provides a novel active principle of plant origin i.e. Acaciaside – B (Ac-B), that possess virucidal and spermicidal properties. The active principle may be useful in the preparation of OTC formulations/vaginal contraceptive for emergency protection against HIV-1 infection during heterosexual interaction or unwanted pregnancy. The technology further suggests the method for simultaneous prevention of HIV infection and unwanted pregnancy in a subject. The contraceptive efficacy of Ac-B has been assessed in rabbits by following intravaginal application and the result for the same is given below.
Sector: Fluid systems and components for general use
Country: India
Area of Application: Medical industry.
Keywords: HIV/AIDs,liposomes, microparticles.
Advantages: Ac-B has both virucidal and spermicidal properties Pure Ac-B is a natural compound of herbal origin. Minimum Effective Concentration (MEC) for human spermicidal action is much less (125 microgram/ml) than that of N-9 (200-250 microgram). Ac-B doesn’t interfere with the growth of vaginal microflora. Ac-B threefold larger size than N-9 favours poor absorption through vaginal epithelium and entry into systemic circulation. It doesn’t show any mutagenic and adverse effects on vaginal ecology.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent in Progress
Technical specifications:  
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):  
Upload any relevant document:  
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054

Contact Technology Provider

Technology offer

Interested in this technology?

Request further information or explore potential cooperation with the technology provider.

Express interest

Technology request

Can you help meet this technology need?

Share a relevant technology, expertise or partnership opportunity with APCTT.

Respond to this request